High-resolution CT of complications of idiopathic fibrotic lung disease

British Journal of Radiology

Volumn 84, Issue 1003, 2011, Pages 581-592

  Lloyd, Claire R ^b   Walsh M, S L F ^a   Hansell, M ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GAMMA1B INTERFERON; GEFITINIB; GOLD SALT; IMMUNOMODULATING AGENT; METHOTREXATE; PIRFENIDONE; PLACEBO; PREDNISOLONE; STEROID;

BRONCHIECTASIS; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SURVIVAL; CARDIOGENIC LUNG EDEMA; CHRONIC NECROTIZING ASPERGILLOSIS; CLINICAL TRIAL (TOPIC); COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DISEASE EXACERBATION; DISSEMINATED DENDRIFORM PULMONARY OSSIFICATION; DRUG INDUCED DISEASE; DRUG INDUCED PNEUMONITIS; DRUG MEGADOSE; FIBROSING ALVEOLITIS; HEART CATHETERIZATION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INVASIVE ASPERGILLOSIS; LUNG ADENOCARCINOMA; LUNG ASPERGILLOSIS; LUNG BIOPSY; LUNG CALCIFICATION; LUNG CANCER; LUNG CARCINOGENESIS; LUNG EDEMA; LUNG EMBOLISM; LUNG INFECTION; LUNG LOBECTOMY; LUNG PARENCHYMA; LUNG RESECTION; LUNG SEGMENTECTOMY; LUNG TUBERCULOSIS; LUNG WEDGE RESECTION; MYCETOMA; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS PNEUMONIA; PNEUMOMEDIASTINUM; PNEUMONIA; PNEUMOTHORAX; PROGNOSIS; PULMONARY HYPERTENSION; REVIEW; SPONTANEOUS PNEUMOTHORAX;

BACTERIAL INFECTIONS; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG DISEASES; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79959583346     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/65090500     Document Type: Review

References (82)

1. American Thoracic Society/European Respiratory Society. International multidisciplinary consensus classification of idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002;165:277-304.
2. Bjoraker JA, Ryu JH, Edwin MK, Myers JL, Tazelaar HD, Schroeder DR, et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998;157:199-203. (Pubitemid 28071283)
3. Mapel DW, Hunt WC, Utton R, Baumgartner KB, Samet JM, Coultas DB. Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts. Thorax 1998;53:469-76. (Pubitemid 28308062)
4. Hubbard R, Johnston I, Britton J. Survival in patients with cryptogenic fibrosis alveolitis: a population-based cohort study. Chest 1998;113:396-400. (Pubitemid 28110017)
5. Nicholson AG, Colby TV, du Bois RM, Hansell DM, Wells AU. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 2000;162:2213-17. (Pubitemid 32051689)
6. Martinez FJ, Safrin S, Weycker D, Starko KM, Bradford WZ, King TE, Jr, et al. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med 2005;142:963-7.
7. Travis WD, Matsui K, Moss J, Ferrans VJ. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns. Survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 2000;24:19-33. (Pubitemid 30033393)
8. Noth I, Martinez FJ. Recent advances in idiopathic pulmonary fibrosis. Chest 2007;132:637-50. (Pubitemid 47282399)
9. Hyzy R, Huang S, Myers J, Flaherty K, Martinez F. Acute exacerbation of idiopathic pulmonary fibrosis. Chest 2007;132:1652-8. (Pubitemid 350156025)
10. Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006;129:746-52.
11. Hunninghake GW, Lynch DA, Galvin JR, Gross BH, Müller N, Schwartz DA, et al. Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest 2003;124:1215-23. (Pubitemid 37290029)
12. Flaherty KR, Thwaite EL, Kazerooni EA, Gross BH, Toews GB, Colby TV, et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 2003;58:143-8. (Pubitemid 36183002)
13. Lynch DA, Godwin JD, Safrin S, Starko KM, Hormel P, Brown KK, et al. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med 2005;172:488-93. (Pubitemid 41117395)
14. Hunninghake GW, Zimmerman MB, Schwartz DA, King TE, Jr, Lynch J, Hegele R, et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001;164:193-6. (Pubitemid 34001280)
15. Chung MJ, Goo JM, Im JG. Pulmonary tuberculosis in patients with idiopathic pulmonary fibrosis. Eur J Radiol 2004;52:175-9. (Pubitemid 39361119)
16. Shachor Y, Schindler D, Siegal A, Lieberman D, Mikulski Y, Bruderman I. Increased incidence of pulmonary tuberculosis in chronic interstitial lung disease. Thorax 1989;44:151-3. (Pubitemid 19056876)
17. Sansom HE, Baque-Juston M, Wells AU, Hansell DM. Lateral cavity wall thickening as an early radiographic sign of mycetoma formation. Eur Radiol 2000;10:387-90. (Pubitemid 30136845)
18. Saraceno JL, Phelps DT, Ferro TJ, Futerfas R, Schwartz DB. Chronic necrotizing pulmonary aspergillosis: approach to management. Chest 1997;112:541-8. (Pubitemid 27349452)
19. Vidal S, de la Horra C, Martín J, Montes-Cano MA, Rodríguez E, Respaldiza N, et al. Pneumocystis jirovecii colonisation in patients with interstitial lung disease. Clin Microbiol Infect 2006;12:231-5. (Pubitemid 43379323)
20. Yale SH, Limper AH. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc 1996;71:5-13. (Pubitemid 26021784)
21. Reittner P, Ward S, Heyneman L, Johkoh T, Müller NL. Pneumonia: high-resolution CT findings in 114 patients. Eur Radiol 2003;13:515-21. (Pubitemid 36790524)
22. Park S, Suh GY, Chung MP, Kim H, Kwon OJ, Lee KS, et al. Clinical significance of Mycobacterium fortuitum isolated from respiratory specimens. Respir Med 2008;102:437-42. (Pubitemid 351179976)
23. Gefter WB. The spectrum of pulmonary aspergillosis. J Thorac Imaging 1992;7:56-74.
24. Buckingham SJ, Hansell DM. Aspergillus in the lung: diverse and coincident forms. Eur Radiol 2003;13:1786-1800. (Pubitemid 36949705)
25. Roberts CM, Citron KM, Strickland B. Intrathoracic aspergilloma: role of CT in diagnosis and treatment. Radiology 1987;165:123-8. (Pubitemid 17146994)
26. Turner-Warwick M, Lebowitz M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis and lung cancer. Thorax 1980;35:496-9. (Pubitemid 10039553)
27. Hubbard R, Venn A, Lewis S, Britton J. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med 2000;161:5-8. (Pubitemid 30055895)
28. Le Jeune I, Gribbin J, West J, Smith C, Cullinan P, Hubbard R. The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK. Respir Med 2007;101:2534-40. (Pubitemid 47618391)
29. Ozawa Y, Suda T, Naito T, Enomoto N, Hashimoto D, Fujisawa T, et al. Cumulative incidence of and predictive factors for lung cancer in IPF. Respirology 2009;14:723-8.
30. Aubry MC, Myers JL, Douglas WW, Tazelaar HD, Washington Stephens TL, Hartman TE, et al. Primary pulmonary carcinoma in patients with idiopathic pulmonary fibrosis. Mayo Clin Proc 2002;77:763-70. (Pubitemid 34847718)
31. Park J, Kim DS, Shim TS, Lim CM, Koh Y, Lee SD, et al. Lung cancer in patients with idiopathic pulmonary fibrosis. Eur Respir J 2001;17:1216-19. (Pubitemid 32717481)
32. Sato T, Yamadori I, Fujita J, Hamada N, Yonei T, Bandoh S, et al. Three cases of non-specific interstitial pneumonia associated with primary lung cancer. Intern Med 2004;43:721-6. (Pubitemid 39264175)
33. Daniels CE, Jett JR. Does interstitial lung disease predispose to lung cancer? Curr Opin Pulm Med 2005;11:431-7.
34. Raghu G, Nyberg F, Morgan G. The epidemiology of interstitial lung disease and its association with lung cancer. Br J Cancer 2004;91S2:S3-S10. (Pubitemid 39334843)
35. Hironaka M, Fukayama M. Pulmonary fibrosis and lung carcinoma: a comparative study of metaplastic epithelia in honeycombed areas of usual interstitial pneumonia with or without lung carcinoma. Pathol Int 1999;49:1060-6. (Pubitemid 30193504)
36. Lee HJ, Im JG, Ahn, JM, Yeon KM. Lung cancer in patients with idiopathic pulmonary fibrosis: CT findings. J Comput Assist Tomogr 1996;20:979-82. (Pubitemid 26392566)
37. Sakai S, Ono M, Nishio T, Kawarada Y, Nagashima A, Toyoshima S. Lung cancer associated with diffuse pulmonary fibrosis: CT-pathologic correlation. J Thorac Imaging 2003;18:67-71. (Pubitemid 38067277)
38. Kawai T, Yakumaru K, Suzuki M, Kageyama K. Diffuse interstitial pulmonary fibrosis and lung cancer. Acta Pathol Jpn 1987;37:11-19. (Pubitemid 17018369)
39. Matsushita H, Tanaka S, Saiki Y, Hara M, Nakata K, Tanimura S, et al. Lung cancer associated with usual interstitial pneumonia. Pathol Int 1995;45:925-32. (Pubitemid 26036957)
40. Mizushima Y, Kobayashi M. Clinical characteristics of synchronous multiple lung cancer associated with idiopathic pulmonary fibrosis. Chest 1995;108:1272-17.
41. Kishi K, Homma S, Kurosaki A, Motoi N, Yoshimura K. High-resolution computed tomography findings of lung cancer associated with idiopathic pulmonary fibrosis. J Comput Assist Tomogr 2006;30:95-9. (Pubitemid 43052306)
42. Kumar P, Goldstraw P, Yamada K, Nicholson AG, Wells AU, Hansell DM, et al. Pulmonary fibrosis and lung cancer: Risk and benefit analysis of pulmonary resection. J Thorac Cardiovasc Surg 2003;125:1321-7. (Pubitemid 36759232)
43. Watanabe A, Higami T, Ohori S, Koyanagi T, Nakashima S, Mawatari T. Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis? J Thorac Cardiovasc Surg 2008;136:1357-63.
44. Kawasaki H, Nagai K, Yoshida J, Nishimura M, Nishiwaki Y. Postoperative morbidity, mortality, and survival in lung cancer associated with idiopathic pulmonary fibrosis. J Surg Oncol 2002;81:33-7. (Pubitemid 34983164)
45. Kushibe K, Kawaguchi T, Takahama M, Kimura M, Tojo T, Taniguchi S. Operative indications for lung cancer with idiopathic pulmonary fibrosis. Thorac Cardiovasc Surg 2007;55:505-8.
46. Takeda A, Enomoto T, Sanuki N, Nakajima T, Takeda T, Sayama K, et al. Acute exacerbation of subclinical idiopathic pulmonary fibrosis triggered by hypofractionated stereotactic body radiotherapy in a patient with primary lung cancer and slightly focal honeycombing. Radiat Med 2008;26:504-7.
47. Kudoh S, Kato H, Nishiwaki Y, Fukuoka M, Nakata K, Ichinose U, et al. Interstitial lung disease in Japanese patients with lung cancer: A cohort and nested case-control study. Am J Respir Crit Care Med 2008;177:1348-57. (Pubitemid 351860912)
48. Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, King TE Jr, et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care, Med 2007;176:636-43. (Pubitemid 47503070)
49. Fernández Pérez ER, Daniels CE, Schroeder DR, St. Sauver J, Hartman TE, Bartholmai BJ, et al. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: A population-based study. Chest 2010;137:129-37.
50. Kim DS, Park JH, Park BK, Lee JS, Nicholson AG, Colby T. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Respir J 2006;27:143-50. (Pubitemid 43092678)
51. Silva CI, Müller NL, Fujimoto K, Kato S, Ichikado K, Taniguchi H, et al. Acute exacerbation of chronic interstitial pneumonia: High-resolution computed tomography and pathologic findings. J Thorac Imaging 2007;22:221-9. (Pubitemid 47329825)
52. Park IN, Kim DS, Shim TS, Lim CM, Lee SD, Koh Y, et al. Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest 2007;132:214-20. (Pubitemid 47068224)
53. Olson AL, Huie TJ, Groshong SD, Cosgrove GP, Janssen WJ, Schwarz MI, et al. Acute exacerbations of fibrotic hypersensitivity pneumonitis: A case series. Chest 2008;134:844-50.
54. Churg A, Müller NL, Silva CI, Wright JL. Acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias. Am J Surg Pathol 2007;31:277-84. (Pubitemid 46175029)
55. Akira M, Hamada H, Sakatani M, Kobayashi C, Nishioka M, Yamamoto S. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. AJR Am J Roentgenol 1997;168:79-83. (Pubitemid 27014751)
56. Akira M, Kozuka T, Yamamoto S, Sakatani M. Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2008;178:372-8.
57. Homma S, Sakamoto S, Kawabata M, Kishi K, Tsuboi E, Motoi N, et al. Cyclosporin treatment in steroid-resistant and acutely exacerbated interstitial pneumonia. Intern Med 2005;44:1144-50.
58. Azuma A, Nukiwa T, Tsuboi E, Suga M, Abe S, Nakata K, et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2005;171:1040-7. (Pubitemid 40616955)
59. Kizer JR, Zisman DA, Blumenthal NP, Kotloff RM, Kimmel SE, Strieter RM, et al. Association between pulmonary fibrosis and coronary artery disease. Arch Intern Med 2004;164:551-6. (Pubitemid 38314452)
60. Daniels CE, Yi ES, Ryu JH. Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis. Eur Respir J 2008;32:170-4.
61. Panos RJ, Mortenson RL, Niccoli SA, King TE, Jr. Clinical deterioration in patients with idiopathic pulmonary fibrosis: Causes and assessment. Am J Med 1990;88:396-404. (Pubitemid 20147276)
62. Rossi SE, Erasmus JJ, McAdams HP, Sporn TA, Goodman PC. Pulmonary drug toxicity: Radiologic and pathologic manifestations. Radiographics 2000;20:1245-59.
63. Hansell DM, Lynch DA, McAdams HA, Bankier AA. Imaging of diseases of the chest. 5th ed. Elsevier, 2010.
64. Honoré I, Nunes H, Groussard O, Kambouchner M, Chambellan A, Aubier M, et al. Acute respiratory failure after interferon-c therapy of end stage pulmonary fibrosis. Am J Respir Crit Care Med 2003;167:953-7. (Pubitemid 36408159)
65. King TE, Jr, Albera C, Bradford WZ, Costabel U, Hormel P, Lancaster L, et al. Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial. Lancet 2009;374:222-8.
66. Hubbard RB, Smith C, Le Jeune I, Gribbin J, Fogarty AW. The association between idiopathic pulmonary fibrosis and vascular disease: A population-based study. Am J Resp Crit Care Med 2008;178:1257-61.
67. Nathan SD, Barnett SD, Urban BA, Nowalk C, Moran BR, Burton N. Pulmonary embolism in idiopathic pulmonary fibrosis transplant recipients. Chest 2003;123:1758-63. (Pubitemid 36549800)
68. Mayo JR, Remy-Jardin M, Müller NL, Remy J, Worsley DF, Hossein-Foucher C, et al. Pulmonary embolism: prospective comparison of spiral CT with ventilation-perfusion scintigraphy. Radiology 1997;205:447-52. (Pubitemid 27467324)
69. Kim KI, Müller NL, Mayo JR. Clinically suspected pulmonary embolism: Utility of spiral CT. Radiology 1999;210:693-7. (Pubitemid 29124029)
70. King TE Jr, Tooze JA, Schwarz MI, Brown KR, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001;164:1171-81. (Pubitemid 33052246)
71. Shorr AF, Wainright JL, Cors CS, Lettieri CJ, Nathan SD. Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant. Eur Respir J 2007;30:715-21. (Pubitemid 351194832)
72. Devaraj A, Wells AU, Meister MG, Corte TJ, Hansell DM. The effect of diffuse pulmonary fibrosis on the reliability of CT signs of pulmonary hypertension. Radiology 2008;249:1042-9.
73. Zisman DA, Karlamangla AS, Ross DJ, Keane MP, Belperio JA, Saggar R, et al. High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Chest 2007;132:773-9.
74. Arcasoy SM, Christie JD, Ferrari VA, Sutton MS, Zisman DA, Blumenthal NP, et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003;167:735-40. (Pubitemid 36801751)
75. Kuriyama K, Gamsu G, Stern RG, Cann CE, Herfkens RJ, Brundage BH. CT-determined pulmonary artery diameters in predicting pulmonary hypertension. Invest Radiol 1984;19:16-22. (Pubitemid 14182002)
76. Edwards PD, Bull RK, Coulden R. CT measurement of main pulmonary artery diameter. Br J Radiol 1998;71:1018-20.
77. Ng CS, Wells AU, Padley SP. A CT sign of chronic pulmonary arterial hypertension: the ratio of main pulmonary artery to aortic diameter. J Thorac Imaging 1999;14:270-8. (Pubitemid 29470994)
78. Devaraj A, Wells AU, Meister MG, Corte TJ, Wort SJ, Hansell DM. Detection of pulmonary hypertension with multidetector CT and echocardiography alone and in combination. Radiology 2010;254:609-16.
79. Franquet T, Giménez A, Torrubia S, Sabaté JM, Rodriguez-Arias JM. Spontaneous pneumothorax and pneumomediastinum in IPF. Eur Radiol 2000;10:108-13. (Pubitemid 30141137)
80. Mendeloff J. Disseminated nodular pulmonary ossification in the Hamman-Rich lung. Am Rev Respir Dis 1971;103:269-74.
81. Fried ED, Godwin TA. Extensive diffuse pulmonary ossification. Chest 1992;102:1614-15.
82. Kim TS, Han J, Chung MP, Chung MJ, Choi YS. Disseminated dendriform pulmonary ossification associated with usual interstitial pneumonia: incidence and thin-section CT-pathologic correlation. Eur Radiol 2005;15:1581-5. (Pubitemid 41102352)